SLC25A20 and breast carcinoma: The same was true for other cancer cell types, including glioblastoma, breast cancer, lung cancer, colon cancer, and liver cancer, where SLC25A20 knockdown reduced ATP production by 26-70% at a 40 nM siRNA concentration (Figure S4H & I).